NCT00790075View on ClinicalTrials.gov

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

December 31, 2004

Conditions
Agitation
Interventions
DRUG

risperidone

liquid risperidone was administered on a mg/kg basis to a child needing seclusion. 0.015mg/kg was the start dose. Dose was increased to 0.02mg/kg if duration of episode was \>30 minutes.

Trial Locations (1)

11794

StonyBrook University Hospital (StonyBrook University School of Medicine), Stony Brook

All Listed Sponsors
lead

Stony Brook University

OTHER

NCT00790075 - Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children | Biotech Hunter | Biotech Hunter